Indegene Ltd.
Industry:
Pharmaceuticals & Drugs
Issue Details
Open Date
06 May 2024Close Date
08 May 2024Size (in Crs.)
1842.65
Size (Shares)
-Listing On
BSE, NSE
Issue Terms
Price Range
-22Lot Size
33
Type
Book building
Face Value
2
Market Lot
1
Objective of the Issue
1. Repayment/prepayment of indebtedness of one of our Material Subsidiaries, ILSL Holdings, Inc.;2. Funding the capital expenditure requirements of our Company and one of our Material Subsidiaries, Indegene, Inc.; and3. General corporate purposes and inorganic growth.
Description
We are a “digital-first” commercialization company focused exclusively on the global life sciences industry. Our solutionsenable biopharmaceutical, emerging biotech and medical devices companies develop products, launch them in the market, anddrive sales through their life cycle in a more effective, efficient and modern manner. We achieve this by combining over twodecades of healthcare domain expertise and fit-for-purpose technology. Our portfolio of solutions cover all aspects ofcommercial, medical, regulator... Show More
Address
Aspen G4, 3rd Floor , Manyata Embassy Business Park , Outer Ring Road, Nagavara
Bengaluru
560045
State
Karnataka
Phone No.
080-46744567 / 46447777
compliance.officer@indegene.com
Website
www.indegene.com
Promoter Holding
Promoters:
Total Share Capital
-
Offered to Public
-
% Promoter's Holding (Pre-Issue)
-
% Promoter's Holding (Post-Issue)
-
Shares on offer
Total Share Offer
-
Of above offred to public
-
Post Issue shares
NA
Post Issue Promoters
-
Lead Managers to the Issue:
Citigroup Global Markets India Pvt Ltd., JP Morgan India Pvt Ltd, Kotak Mahindra Capital Co Ltd, Nomura Financial Advisory & Securities (India) Pvt Ltd.
Registrar Details
Registrar Name:
Link Intime India Pvt Ltd.
Address
C 101, 247 Park , LBS Marg , Vikhroli (West) , Mumbai
400083
Phone No.
91-022-49186000/49186270
helpdesk@linkintime.co.in
Website
www.linkintime.co.in
Fax
91-022-49186060